Zhejiang CONBA Pharmaceutical Co Ltd Cash Flow Quality Index
Zhejiang CONBA Pharmaceutical Co Ltd cash flow quality index. Zhejiang CONBA Pharmaceutical Co Ltd (600572) has a Cash Flow Quality Index of 0.58x as of September 2025. Operating cash flow of CN¥133.43 Million is below net income of CN¥230.43 Million, suggesting accrual-heavy earnings not yet converted to cash. See 600572 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Zhejiang CONBA Pharmaceutical Co Ltd (2003–2025)
Cash flow quality index of Zhejiang CONBA Pharmaceutical Co Ltd from 2003 to 2025. Historical Cash Flow Quality Index for Zhejiang CONBA Pharmaceutical Co Ltd across 22 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Zhejiang CONBA Pharmaceutical Co Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Zhejiang CONBA Pharmaceutical Co Ltd Cash Flow Quality Index by Year (2003–2025)
Zhejiang CONBA Pharmaceutical Co Ltd cash flow quality index by year from 2003 to 2025. Year-by-year earnings quality comparison for Zhejiang CONBA Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 600572 cash flow conversion.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.99x | CN¥942.61 Million | CN¥474.36 Million | ▲ +22.2% |
| 2024 | 1.63x | CN¥1.01 Billion | CN¥622.42 Million | ▲ +22.1% |
| 2023 | 1.33x | CN¥898.64 Million | CN¥674.72 Million | ▼ -47.0% |
| 2022 | 2.51x | CN¥1.16 Billion | CN¥460.09 Million | ▲ +498.2% |
| 2021 | 0.42x | CN¥889.94 Million | CN¥2.12 Billion | ▼ -81.5% |
| 2020 | 2.28x | CN¥1.25 Billion | CN¥549.20 Million | ▲ +237.0% |
| 2018 | 0.68x | CN¥545.78 Million | CN¥808.34 Million | ▼ -30.8% |
| 2017 | 0.98x | CN¥712.27 Million | CN¥729.97 Million | ▼ -59.3% |
| 2016 | 2.40x | CN¥969.71 Million | CN¥404.14 Million | ▲ +45.4% |
| 2015 | 1.65x | CN¥831.26 Million | CN¥503.71 Million | ▲ +94.5% |
| 2014 | 0.85x | CN¥617.43 Million | CN¥727.75 Million | ▲ +63.7% |
| 2013 | 0.52x | CN¥235.36 Million | CN¥454.22 Million | ▼ -27.7% |
| 2012 | 0.72x | CN¥245.76 Million | CN¥342.80 Million | ▲ +16.6% |
| 2011 | 0.61x | CN¥188.36 Million | CN¥306.43 Million | ▼ -2.0% |
| 2010 | 0.63x | CN¥125.93 Million | CN¥200.83 Million | ▼ -57.0% |
| 2009 | 1.46x | CN¥153.39 Million | CN¥105.20 Million | ▲ +37.0% |
| 2008 | 1.06x | CN¥98.56 Million | CN¥92.60 Million | ▲ +50.1% |
| 2007 | 0.71x | CN¥79.98 Million | CN¥112.83 Million | ▼ -38.8% |
| 2006 | 1.16x | CN¥71.20 Million | CN¥61.49 Million | ▼ -53.6% |
| 2005 | 2.49x | CN¥117.65 Million | CN¥47.17 Million | ▲ +18.3% |
| 2004 | 2.11x | CN¥65.47 Million | CN¥31.05 Million | ▲ +26.8% |
| 2003 | 1.66x | CN¥66.64 Million | CN¥40.07 Million | — |